文献速递慢性肾脏病

细胞外液容量与非透析慢性肾脏病患者的终末期肾病及死亡相关

Extracellular fluid volume is associated with incident end-stage kidney disease and mortality in patients with chronic kidney disease.
PubMed 文献 · Kidney Int · 2019-07-16

在1593例CKD 1-4期患者的前瞻性队列中,用51Cr-EDTA分布容积测定细胞外液容量(ECF),中位随访5.3年。ECF每增加1 L/1.73m²,ESKD风险独立升高(HR 1.14),GFR下降更快;ECF>15 L/1.73m²时死亡风险显著升高。

要点

  • ECF容量是CKD进展和死亡的独立危险因素。
  • ECF每升高1 L/1.73m²,ESKD风险增加14%。
  • ECF>15 L/1.73m²时死亡风险显著升高,需密切监测容量。

核心结论

  • 在CKD 1-4期患者中,ECF容量是CKD进展和死亡的独立危险因素。

研究设计与样本

  • 前瞻性医院队列NephroTest研究,纳入CKD 1-4期患者1593例,平均年龄58.8岁,67%为男性。
  • 用51Cr-EDTA分布容积测定ECF(按体表面积标化),用清除率测定mGFR。
  • 采用病因特异性Cox回归和线性混合效应模型分析ECF与ESKD、死亡及mGFR下降的关联。

主要发现

  • 中位随访5.3年,324例发生ESKD,185例在ESKD前死亡。
  • 多变量分析中,ECF每增加1 L/1.73m²,ESKD风险HR为1.14(95%CI 1.07-1.21)。
  • ECF每增加1 L/1.73m²,mGFR斜率平均差异为-0.14(95%CI -0.23至-0.05)mL/min/年。
  • ECF与死亡的关系呈非线性:ECF<15 L/1.73m²时HR 0.92(95%CI 0.73-1.16)不显著;ECF>15 L/1.73m²时HR 1.28(95%CI 1.14-1.45)显著。

临床怎么用

  • 对非透析CKD患者应密切监测容量状态,及时治疗液体超负荷。
  • ECF>15 L/1.73m²提示死亡风险升高,需加强干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Volume overload has been shown to be an independent risk factor for mortality in patients receiving chronic dialysis, but data in non-dialysis patients are scarce. Therefore we evaluated the prognostic value of extracellular fluid (ECF) volume for chronic kidney disease (CKD) progression and mortality in a prospective hospital-based cohort with CKD stage 1-4 (NephroTest Study). ECF (scaled to body surface area) and the measured glomerular filtration rate (mGFR) were determined using the distribution volume and clearance of 51Cr-EDTA, respectively. Cause-specific Cox and linear mixed-effect regression models were used to analyze the association of ECF with end-stage kidney disease (ESKD) and mortality, and with mGFR decline, respectively. The 1593 patients were mean age 58.8 years, 67% were men, mean mGFR of 43.6 mL/min/1.73m2 and mean ECF 15.1 L/1.73m2. After a median follow-up of 5.3 years, ESKD occurred in 324 patients and 185 patients died before ESKD. In multivariable analysis, ECF was significantly associated with the risk of ESKD (hazard ratio per 1L/1.73m2 increase: 1.14; 95% confidence interval [1.07; 1.21]) and with a faster GFR decline (adjusted mean difference in mGFR slope per 1L/1.73m2 increase -0.14 [-0.23; -0.05] mL/min/year). The relationship of ECF with mortality was non-linear and not significant (per 1L/1.73m2 increase 0.92, [0.73; 1.16]), below 15L/1.73m2, but significant (1.28; [1.14-1.45]) above 15L/1.73m2. Thus, in this large cohort of carefully phenotyped patients with CKD, ECF was an independent risk factor of CKD progression and mortality. Hence, close monitoring and treatment of fluid overload are important for the clinical management of patients with non-dialysis CKD.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Faucon AL, Flamant M, Metzger M, et al. Extracellular fluid volume is associated with incident end-stage kidney disease and mortality in patients with chronic kidney disease. Kidney Int. 2019. PMID: 31477263. doi:10.1016/j.kint.2019.06.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。